Publications by authors named "Sayaka Hanada"

Claim this Profile
O
Outcome From a Randomized Controlled Clinical Trial　- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).
Takashi Horie, Seiji Yamazaki, Sayaka Hanada, Shuzo Kobayashi, Tatsuo Tsukamoto

Circ J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-guided endovascular treatment for vascular access malfunction: results in 4896 cases.
Masanori Wakabayashi, Sayaka Hanada, Hiroyuki Nakano, Tsunemichi Wakabayashi

J Vasc Access· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.
Rongxin Deng, Xu Wang, Yang Liu, Ming Yan, Sayaka Hanada

J Cell Mol Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.
Hong Pan, Sayaka Hanada, Jun Zhao, Li Mao, Mark Zhi-Qing Ma

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer.
Xi-Hu Yang, Zhi-En Feng, Ming Yan, Sayaka Hanada, Hui Zuo

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis